ProShares Trust - ProShares UltraShort S&P500 -2x Shares
SDS
Market Cap$30.41M
Close$
$-6.98
145.4% downside
Current Fair Value
145.4% downsideOvervalued by 145.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $30.41 Million |
|---|---|
| Enterprise Value | $-170,959,008.00 |
| Dividend Yield | $1.17 (7.52%) |
| Earnings per Share | $-19.86 |
| Beta | -1.96 |
| Outstanding Shares | 3,518,625 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -7.68 |
|---|---|
| PEG | 0.2 |
| Price to Sales | 3.07 |
| Price to Book Ratio | 0.19 |
| Enterprise Value to Revenue | -9.35 |
| Enterprise Value to EBIT | 6.26 |
| Enterprise Value to Net Income | 5 |
| Total Debt to Enterprise | -0.11 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About BioAge Labs, Inc.
62 employees
CEO: Dr. Kristen Fortney Ph.D. BioAge Labs, Inc. is a clinical-stage biopharmaceutical company that develops therapeutic product candidates for metabolic diseases. The company's technology platform and differentiated human datasets allows users to identify targets bas...